Skip to main content

Table 1 Pooled data from randomized clinical trials of oral magnesium supplementation in pregnancy for the prevention of adverse pregnancy outcomes

From: The BRAzil MAGnesium (BRAMAG) trial: a randomized clinical trial of oral magnesium supplementation in pregnancy for the prevention of preterm birth and perinatal and maternal morbidity

Outcome

Number of participants (RCTs) included

Control event rate (per 1000)

Magnesium supplementation event rate (per 1000)

Relative risk reduction,% (95% confidence interval)

Preterm birth < 37 weeks gestation

2275 (5)

105

67

27 (6 to 43)

Preeclampsia

474 (2)

167

145

13 (−32 to 43)

Small for gestational age birthweight < 10 percentile

1741 (3)

119

83

30 (7 to 47)

  1. Based on reference [35].